Fetal and neonatal alloimmune thrombocytopenia

Area of Science:

• Perinatology
• Immunology
• Hematology

Background:

• Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare but serious condition.
• Limited preventive measures and uncertain therapeutic results complicate management.
• Intravenous immunoglobulin (IVIG) is a partially accepted but expensive treatment for FNAIT.

Observation:

• This case report details the management of FNAIT in a single patient.
• The patient experienced a fetal demise in her first pregnancy.
• The second pregnancy resulted in a healthy infant despite FNAIT.

Findings:

• The patient's treatment experience did not align with literature suggesting IVIG improves outcomes.
• The first pregnancy resulted in intrauterine fetal demise (IUFD).
• The second pregnancy was successful, with the delivery of a healthy child.

Implications:

• FNAIT poses significant risks, including intracranial bleeding and prenatal death.
• Therapeutic strategies for FNAIT require further investigation due to variable results.
• This case highlights the unpredictable nature of FNAIT and its management.